Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition. Cancer Res. 2013 May 15; 73(10):3087-96.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.